Akorn Backs Full-year Forecast - Quick Facts

(RTTNews) - Akorn, Inc. (AKRX), a specialty pharmaceutical company, Tuesday reaffirmed its 2015 earnings per share metrics issued on February 26, calling for revenue between $960 million and $980 million and adjusted earnings per share of between $1.88 and $1.98.

On average, 13 analysts polled by Thomson Reuters expect earnings of $1.98 per share for the year. Analysts' estimates typically exclude special items.

Analysts look for revenues of $973.80 million.

Akorn's Chief Financial Officer Tim Dick will present at the Barclays Global Healthcare Conference on March 12.

AKRX, which closed at $51.84 on Monday, fell 5.7 percent in pre-market activity.